Genelux (GNLX) Current Assets (2022 - 2026)
Genelux (GNLX) posted Current Assets of $26.8 million for Q1 2026, up 76.83% on a QoQ basis from $15.1 million in Q4 2025.
Analysis
Genelux (GNLX) Current Assets (2022 - 2026) Analysis & Trends
Genelux has reported Current Assets for 5 years, with the latest figure at $26.8 million in Q1 2026.
- On a quarterly basis, Current Assets changed N/A year-over-year to $26.8 million in Q1 2026; TTM through Mar 2026 was $26.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $15.1 million, down 52.04% from the prior year.
- Current Assets was $26.8 million for Q1 2026 at Genelux, up from $15.1 million in the prior quarter.
- The five-year high for Current Assets was $36.0 million in Q3 2024, with the low at $1.9 million in Q4 2022.
- Average Current Assets over 5 years is $24.9 million, with a median of $26.8 million recorded in 2026.
- The sharpest annual moves came in 2023 and 2025: Current Assets surged 1179.23% in 2023, then slumped 52.04% in 2025.
- Over 5 years, Current Assets stood at $1.9 million in 2022, then soared by 1179.23% to $24.2 million in 2023, then jumped by 30.35% to $31.5 million in 2024, then plunged by 52.04% to $15.1 million in 2025, then surged by 76.83% to $26.8 million in 2026.
- The last three Current Assets figures came in at $26.8 million (Q1 2026), $15.1 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 4.74 Bn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - | 26.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 26.75 Mn |
| Dec 31, 2025 | 15.13 Mn |
| Sep 30, 2025 | 21.55 Mn |
| Jun 30, 2025 | 29.24 Mn |
| Dec 31, 2024 | 31.55 Mn |
| Sep 30, 2024 | 35.97 Mn |
| Jun 30, 2024 | 34.87 Mn |
| Mar 31, 2024 | 21.20 Mn |
| Dec 31, 2023 | 24.20 Mn |
| Sep 30, 2023 | 31.18 Mn |
| Dec 31, 2022 | 1.89 Mn |